Morning Breakouts

Latest KFF Health News Stories

Justice Department Initiative Targeting Synthetic Opioids Will Hyper-Focus On Counties To Try To Eradicate Drugs

Morning Briefing

Attorney General Jeff Sessions announced the project, which is based on a successful model in Manatee County, Florida. The program will provide a new assistant U.S. attorney to districts in New Hampshire, California, Kentucky, Maine, Ohio, Pennsylvania, Tennessee and West Virginia.

FDA Wants To Be Granted Expanded Authority To Intervene In Drug Shortages

Morning Briefing

While the number of drugs in shortage is down from a peak several years ago, many supply interruptions are lasting much longer — sometimes well over a year. Right now, there’s not much the agency can do, but FDA Commissioner Scott Gottlieb says he wants to get more aggressive in protecting patients from the shortfalls.

Pfizer CEO Has Knack For Making A Profit, But He Misplayed The Optics Of Raising Prices In Current Atmosphere

Morning Briefing

Like clockwork, Pfizer has been raising prices every six months, flying under the radar because most pharma companies were doing the same. But then the company caught the attention of President Donald Trump, and everything changed. In other pharmaceutical news: Novartis ditches antibiotics research; a patient advocacy group highlights a New Jersey candidate’s ties to high prices; and an experimental epilepsy drug moves forward toward approval.

CMS Chief Puts Blame On The Court For Decision To Freeze Payments To Insurers

Morning Briefing

A federal court ruling in New Mexico found the Trump administration did not properly justify its formula for dispensing the funds. “We’ve been trying to figure out, is there a solution? We understand the impact to the market [but] we have to follow what the courts say,” CMS Administrator Seema Verma said.

Democrats Using ACA Threat As Talking Point Against Kavanaugh Exaggerate His Hostility To The Law

Morning Briefing

The New York Times fact checks some of the rhetoric being used as the nomination battle heats up. Meanwhile, though Democrats are painting a grim picture about what would happen to the health law if Brett Kavanaugh is approved, it’s unlikely that the Supreme Court will wholesale upend the legislation.

State Democrats Begin Scouring Their Books For Old, Unenforced Laws Banning Abortion

Morning Briefing

With Brett Kavanaugh’s nomination for the Supreme Court seat, both Republican and Democratic states are readying for what would happen if Roe v. Wade is overturned and abortion rights are thrown back to the states. Meanwhile, polling shows continued support from Americans for upholding Roe.

All Eligible Children Under 5 Reunited With Families, But Thousands Of Older Kids Still In Custody

Morning Briefing

The government scrambles to fulfill a judge’s order regarding the younger children being held. There are still 46 kids under the age of 5 that weren’t released due to a variety of reasons, such as their parents having been accused of serious crimes.

Creating A Safety Plan For Patients Who End Up In Hospital For Suicide Attempt Can Have ‘Phenomenal’ Results

Morning Briefing

The small step has proven to be simple yet effective at a time when patients are at their most vulnerable for another attempt. In other public health news: high blood pressure, diets, positive people, mysterious attacks, anti-aging drugs, and more.

New, Faster Method Of Gene Editing Allows Scientists To Turn T Cells Into ‘Living Cancer Drugs’

Morning Briefing

“We’re living in an amazing moment in cancer immunotherapies,” said microbiologist Alexander Marson, co-author of the study that appears in Nature. In other news on cancer research, “re-homing” cells are found to improve survival in mice.

Distributors Funneled Equivalent Of About 260 Opioid Pills For Every Person Into Missouri During 5-Year Period

Morning Briefing

The findings come from a congressional investigation into drug distributors and their potential failure to report suspicious prescription activity. The report, in particular, focused on the disparity between what AmerisourceBergen and McKesson flagged. The two distributors shipped nearly identical volumes of opioids to Missouri, but the number of suspicious orders each company reported were nowhere close: 224 from AmerisourceBergen and 16,714 from McKesson.

Millions In Funding For Gun Violence Research Rejected By Republican Appropriators

Morning Briefing

The lawmakers argued that the CDC is already free to study firearm injuries and that the language would risk further politicizing the spending bill. News on health savings accounts and drugged driving also comes out of Capitol Hill.

Under Pressure, Trump Administration Expected To Streamline Process Of Reuniting Separate Families

Morning Briefing

To speed up the reunions, the government will no longer insist on fingerprinting all adults in a household where a child will live, or require home visits by a social worker. Meanwhile, tech issues aren’t helping the problems. And lawmakers’ tarrying at a House Appropriations Committee highlights just how hard it will be to pass immigration measures in this Congress.

Health Care A Talking Point In Democrats’ Kavanaugh Strategy. But So Are Unions And Guns And LGBTQ Rights And …

Morning Briefing

Where as the GOP has picked one message to focus on for the Supreme Court nomination battle — Brett Kavanaugh’s credentials — Democrats are being pulled in a lot of different directions. “We have a long history of making simple arguments overly complicated, and we have a long history of thinking that we need to compartmentalize our messages for different groups,” said Sen. Chris Murphy (D-Conn.). “We need to get over both of those addictions if we are going to defeat Brett Kavanaugh.”